Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (371-380 of 548) with videos related to

Pageof 55
Sort By:
International Journal of Environmental Research and Public Health|November 18, 2020
Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain StudyJéssica Alonso-Molero, Trinidad Dierssen-Sotos, Ines Gomez-Acebo, et al.
Nature Communications|May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trialsNeil H Segal, Ignacio Melero, Victor Moreno, et al.
Plos One|August 11, 2016
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain StudyInés Gómez-Acebo, Trinidad Dierssen-Sotos, Camilo Palazuelos, et al.
Carcinogenesis|November 20, 2012
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populationsCeres Fernandez-Rozadilla, Claire Palles, Luis Carvajal-Carmona, et al.
Nature Photonics|March 13, 2023
Laser-guided lightningAurélien Houard, Pierre Walch, Thomas Produit, et al.
Nature Cancer|May 1, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trialIgnacio Melero, Bernhard Reis, Corinne Rusterholz, et al.
BMC Medicine|October 2, 2025
Investigating the relationship of plasma microRNAs and colorectal cancer risk using genetic evidenceEmmanouil Bouras, Christos K Papagiannopoulos, Rima Mustafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
Mutational Heterogeneity in <i>APC</i> and <i>KRAS</i> Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal TumorigenesisMireia Gausachs, Ester Borras, Kyle Chang, et al.
Scandinavian Journal of Work, Environment & Health|March 3, 2017
Shift work and colorectal cancer risk in the MCC-Spain case-control studyKyriaki Papantoniou, Gemma Castaño-Vinyals, Ana Espinosa, et al.
Environmental Health Perspectives|April 25, 2018
Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study)Ariadna Garcia-Saenz, Alejandro Sánchez de Miguel, Ana Espinosa, et al.
Pageof 55

Showing results (371-380 of 548) with videos related to

Sort By:
Pageof 55
International Journal of Environmental Research and Public Health|November 18, 2020
Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain StudyJéssica Alonso-Molero, Trinidad Dierssen-Sotos, Ines Gomez-Acebo, et al.
Nature Communications|May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trialsNeil H Segal, Ignacio Melero, Victor Moreno, et al.
Plos One|August 11, 2016
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain StudyInés Gómez-Acebo, Trinidad Dierssen-Sotos, Camilo Palazuelos, et al.
Carcinogenesis|November 20, 2012
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populationsCeres Fernandez-Rozadilla, Claire Palles, Luis Carvajal-Carmona, et al.
Nature Photonics|March 13, 2023
Laser-guided lightningAurélien Houard, Pierre Walch, Thomas Produit, et al.
Nature Cancer|May 1, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trialIgnacio Melero, Bernhard Reis, Corinne Rusterholz, et al.
BMC Medicine|October 2, 2025
Investigating the relationship of plasma microRNAs and colorectal cancer risk using genetic evidenceEmmanouil Bouras, Christos K Papagiannopoulos, Rima Mustafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
Mutational Heterogeneity in <i>APC</i> and <i>KRAS</i> Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal TumorigenesisMireia Gausachs, Ester Borras, Kyle Chang, et al.
Scandinavian Journal of Work, Environment & Health|March 3, 2017
Shift work and colorectal cancer risk in the MCC-Spain case-control studyKyriaki Papantoniou, Gemma Castaño-Vinyals, Ana Espinosa, et al.
Environmental Health Perspectives|April 25, 2018
Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study)Ariadna Garcia-Saenz, Alejandro Sánchez de Miguel, Ana Espinosa, et al.
Pageof 55